Market Tracker

10/24 6:06am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

7.49
Data as of Oct 23
 -0.35 / -4.46%
Today’s Change
6.05
Today|||52-Week Range
11.47
-0.66%
Year-to-Date

Today’s Trading

Previous close7.84
Today’s open7.97
Day’s range-- - --
Volume483,095
Average volume (3 months)406,086
Market cap$336.5M
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+100.45%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book9.37

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.30+2.99%
VVUSVIVUS Inc+0.08+2.41%
PTXPernix Therapeutics ...+0.03+0.33%
XNCRXencor Inc+0.26+2.54%
Data as of 10/23/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.44
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts